Can Emerging Markets Fuel Growth And Restore Trust In Pharma?

When looking at emerging markets, most biopharma analysts focus on commercial opportunities - whether "pharmerging" markets will help mitigate lost sales in the U.S. and Europe stemming from the patent cliff, increasing pressure from payers and related challenges